Both decreased CD8+ T-cell reactivity to EBV-infected B cells in patients with MS [185] and a significant increase in the frequency of CD8+ T cells specific for EBV proteins expressed in infected B cells [186], have been reported. Here, CD8A is linked to myeloid sarcoma.